Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-10-053843)

Filing Details

Accession Number:: 0001209191-10-053843
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-11-09 09:22:54
Reporting Period:: 2010-11-05

Filing Date:: 2010-11-09
Accepted Time:: 2010-11-09 09:22:54
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1003642	Impax Laboratories Inc	IPXL	Pharmaceutical Preparations (2834)	650403311

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1336015	Christopher Mengler	C/O Impax Laboratories, Inc. 30831 Huntwood Avenue Hayward CA 94544		No	No	No	Yes

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2010-11-05	7,460	$19.32	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The price reported in Column 4 is a weighted average price reflecting the following individual transactions: 100 shares at $19.22; 700 shares at $19.24; 200 shares at $19.25; 1,600 shares at $19.27; 100 shares at $19.28; 310 shares at $19.29; 300 shares at $19.31; 100 shares at $19.33; 100 shares at $19.34; 1,200 shares at $19.35; 600 shares at $19.36; 700 shares at $19.37; 700 shares at $19.38; and 750 shares at $19.40.